Back to results
US 10,292,979 B2Granted
Methods of treating cancer patients with farnesyltransferase inhibitors
AssigneeKura Oncology, Inc.
InventorsAntonio Gualberto, Catherine Rose Scholz
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of molecular biology and cancer biology. Specifically, the present invention relates to methods of treating a subject with a farnesyltransferase inhibitor (FTI) that include determining whether the subject is likely to be responsive to the FTI treatment based on genotyping and expression profiling of certain immunological genes and RAS mutation status in the subject.
Claims28
A method of treating a H-Ras mutant non-small cell lung carcinoma in a subject, comprising administering a therapeutically effective amount of tipifarnib to said subject.
Dependencies are inferred from the claim text.